Emma Walmsley is CEO of GSK and a member of the GSK Board. Within GSK, she was also CEO of GSK Consumer Healthcare, a Joint Venture between GSK and Novartis, and has been a member of GSK’s Corporate Executive Team since 2011. She joined GSK in 2010, with responsibility for Consumer Healthcare, Europe.
Emma has had years of leadership experience with companies such as L’Oreal, where she held a variety of marketing and general management roles in Paris, London and New York. With L'Oreal, she was also based in Shanghai as General Manager, Consumer Products for L’Oreal China. Emma is on the Microsoft board as an Independent Director and was a Non-Executive Director of Diageo plc.
Emma also co-chairs the Consumer, Retail and Life Sciences Council, a business advisory group for the UK Government and holds an MA in Classics and Modern Languages from Oxford University.
Emma is supported by further women leaders at GSK
There are many women supporting Emma in GSK's journey. Below, meet the women leaders on GSK's Corporate Executive Team who are responsible for the management of the business and its activities to help deliver extraordinary things for GSK patients and consumers and make the company a brilliant place to work.
Diana Conrad, Senior Vice President, Human Resources
Diana Conrad is Senior Vice President, Human Resources and a member of the Corporate Executive Team. She was previously Senior Vice President, HR, Pharmaceuticals R&D.
Diana joined GSK’s HR team in 2000 in the Canada Sales and Marketing organisation before moving on to several Sales Director roles in the region between 2002 and 2005. After being appointed Vice President, HR, Pharmaceuticals Canada in 2006, Diana held roles of increasing responsibility before becoming Senior Vice President, HR for Consumer Healthcare in 2009. In this role, she successfully led the global HR integration activities for the Joint Venture between GSK and Novartis Consumer businesses. From 2016 to 2019, as Senior Vice President, HR, Pharmaceuticals R&D, Diana played a key strategic role as leader of the R&D culture agenda to support its transformation aligned to GSK’s Innovation, Performance and Trust priorities.
Prior to joining GSK, Diana held HR roles in companies including GE Capital, Gennum Corporation and Zenon Environmental Laboratories and has an Honours Bachelor of Arts from McMaster University.
Sally Jackson, Senior Vice President, Global Communications and CEO Office
Sally Jackson is Senior Vice President, Global Communications and CEO Office, at GSK. She is responsible for communications and government affairs in the three global businesses and in the markets, and for the continued modernisation of employee engagement across GSK. She also serves as the CEO’s Chief of Staff and secretary to the Corporate Executive Team (CET) and supports CET deployment of GSK’s strategy.
Prior to this, Sally was Senior Vice President, Office of the CEO and CFO where she supported development and implementation of GSK’s IPT strategy and co-led the Central Integration Planning Team for GSK’s three-part transaction with Novartis, from deal signing until deal closure. She previously served as Head of Investor Relations. Sally joined the company in 2001 in the Portfolio Analysis group in R&D.
Sally holds a first-class degree in Natural Sciences from the University of Cambridge.
Karenann Terrell, Chief Digital & Technology Officer
Karenann Terrell joined GSK as Chief Digital & Technology Officer with a company-wide remit to transform how new technologies are used to improve performance across the group.
She is responsible for GSK’s digital, data and analytics strategy. She works with a wide range of partners from inside and outside the healthcare sector to bring new technologies to GSK, enhancing areas such as clinical trials and drug development; improving how we interact with healthcare professionals, customers and consumers; and making internal processes more efficient.
Karenann’s previous role was Chief Information Officer for Walmart, where she led a multi-year effort to transform Walmart in the use of data, analytics and digital engagement with its customers. Prior to Walmart she was at Baxter International, where she was Chief Information Officer, and before that Daimler Chrysler Corporation. Karenann began her career in General Motors and held various roles in manufacturing, engineering and brand management.
Karenann is a member of the board of trustees for the New York Hall of Science and in 2017 she became a Non-Executive Director of Pluralsight LLC. She earned graduate and post-graduate degrees in Electrical Engineering from Kettering University and Purdue University, respectively.
Deborah Waterhouse, CEO of ViiV Healthcare
Deborah Waterhouse is Chief Executive Officer of ViiV Healthcare. ViiV Healthcare is majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders.
Deborah joined GSK in 1996 and was most recently the Senior Vice President of Primary Care within the company’s US business, prior to which she led the US Vaccines business.
She brings a wealth of experience to GSK having lived and worked in Europe, Asia Pacific and the USA, and a strong track record of performance in both speciality and primary care. Deborah led the HIV business in the UK before heading the HIV Centre of Excellence for Pharma Europe, and held international roles as General Manager of Australia and New Zealand and Senior Vice President for Central and Eastern Europe.
Forge a career in leadership at GSK
Do you want to help lead a group that aims to be the world’s most innovative, best performing and trusted healthcare company?
GSK is looking for women leaders. If you want to take on a challenge and make a global impact, search and apply for jobs with GSK today.
Find out more
Disclosure: Where Women Work researches and publishes insightful evidence about how its paid member organizations support women's equality.